PERSPECTA

News from every angle

← Back to headlines

UK Regulator Pauses Puberty Blocker Trial, Raising Questions on Regulatory Process

The MHRA's decision to pause a puberty blocker trial has led to scrutiny and questions regarding the regulatory process behind such medical interventions.

26 Feb, 11:55 — 26 Feb, 11:55
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

New Statesman13h ago

Inside the decision to pause the puberty blocker trial

The MHRA’s U-turn raises questions over regulatory process

By Hannah Barnes

Read full article →

Related Stories

Doctors’ goal: Zero dengue deaths by year 2030 

just now

To check cervical cancer, vaccines and information must go together

21m ago

First 30 Vietnamese nurses graduate from Austria's training program

23m ago

'Bachelor' Star Megan Marx Shares Journey with Rare Brain Disorder

23m ago